According to @ReutersBiz, Novo Nordisk shares fell as much as 6.4% intraday after President Trump signalled the price of the Danish drugmaker's weight-loss drugs would be lowered, source: Reuters Business. No details on peer stock moves or any crypto market impact were reported in the update, source: Reuters Business.